G01N 2333/91057
With definite ec number
Official title: with definite EC number (2.3.1.-)
G01N2333/91057 (With definite ec number) appears on 39 US grants and 98 published applications in this corpus.
Search patents in G01N- Granted patents
- 39
- Published applications
- 98
- Assignees
- 81
- Inventors
- 252
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 2 |
| 2002 | 1 | 1 |
| 2003 | 0 | 3 |
| 2004 | 2 | 1 |
| 2005 | 0 | 3 |
| 2006 | 0 | 3 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 2 | 7 |
| 2011 | 2 | 3 |
| 2012 | 1 | 1 |
| 2013 | 1 | 4 |
| 2014 | 2 | 6 |
| 2015 | 1 | 5 |
| 2016 | 2 | 4 |
| 2017 | 2 | 3 |
| 2018 | 2 | 5 |
| 2019 | 2 | 4 |
| 2020 | 4 | 5 |
| 2021 | 1 | 4 |
| 2022 | 3 | 8 |
| 2023 | 1 | 5 |
| 2024 | 3 | 6 |
| 2025 | 2 | 10 |
| 2026 | 3 | 2 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Predicting prognosis and treatment response of breast cancer patients using expression and cellular localization of N-myristoyltransferase19 May 2026US 12,631,646 B2Oncodrex Inc.
- Methods for modulation of acetyltransferase activity and applications thereof including treatments12 May 2026US 12,625,139 B2The Board of Trustees of the Leland Stanford Junior University
- Use of Acyl coenzyme A: cholesterol acyltransferase-1 in diagnosis and treatment of liver cancer3 Feb 2026US 12,540,943 B2Academy of Military Medical Sciences
- Chloramphenicol resistant split protein and uses thereof30 Sep 2025US 12,428,637 B2Technology Innovation Momentum Fund (Israel) Limited Partnership
- Probe for universal detection of circulating tumor cells21 Jan 2025US 12,203,935 B2University of Houston System
- Methods of controlled cleavage2 Jul 2026US 2026/0185996 A1Quantum-Si Incorporated
- Lactylated nijmegen breakage syndrome 1 protein and uses thereof4 Jun 2026US 2026/0153511 A1The Seventh Affiliated Hospital, Sun Yat-Sen University
- Chloramphenicol resistant split protein and uses thereof30 Oct 2025US 2025/0333724 A1Technology Innovation Momentum Fund (Israel) Limited Partnership
- Expression systems for the alpha6beta4 nicotinic acetylcholine receptor and methods of use thereof4 Sep 2025US 2025/0277784 A1
- Method of measuring level of immune suppression21 Aug 2025US 2025/0264460 A1The Johns Hopkins University
Most cited
By later US patents
- Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme640US 9,371,394 B2Dow AgroSciences LLC · 2016
- Method and assay for determining FAS expression35US 8,685,891 B2Nuclea Biotechnologies, Inc. · 2014
- Method for the asymmetric synthesis of beta-lactone compounds9US 7,728,153 B2Burnham Institute for Medical Research · 2010
- Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation9US 7,799,826 B2Burnham Institute for Medical Research · 2010
- Scintillation proximity assay for type II fatty acid biosynthetic enzymes5US 6,475,751 B2Virginia Commonwealth University · 2002